TrialEuropean journal of endocrinology2022

Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial.

R A Ajjan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.